CircZNF609 Aggravated Myocardial Ischemia Reperfusion Injury via Mediation of miR-214-3p/PTGS2 Axis
Author:
Affiliation:
1. Department of Anesthesiology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, P.R. China.
Funder
Natural Science Foundation of Hunan Province
Foundation of Hunan Provincial Education Department
Hunan Provincial Health Commission
Publisher
The Korean Society of Cardiology
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://e-kcj.org/pdf/10.4070/kcj.2021.0252
Reference29 articles.
1. Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI)
2. Vaspin protects rats against myocardial ischemia/reperfusion injury (MIRI) through the TLR4/NF-κB signaling pathway
3. Involvement of Nrf2 in myocardial ischemia and reperfusion injury
4. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway
5. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications;Biochemical Pharmacology;2024-06
2. Cardiomyocyte Autophagy: A Novel Therapeutic Target by LncRNA PART1;Korean Circulation Journal;2024
3. Imb16-4 Targets Ptgs2/Nf-ĸb Signaling Pathway to Regulate Phenotypic Transformation of Vascular Smooth Muscle Cells and Slow the Development of Abdominal Aortic Aneurysms;2024
4. Identification of novel prognostic targets in coronary artery disease and related complications using bioinformatics and next generation sequencing data analysis;2023-02-22
5. LOXL1-AS1/miR-761/PTEN as a Novel Signaling Pathway in Myocardial Ischemia and Reperfusion Injury (MIRI): Epigenetic Regulation by Long Non-Coding RNA (LncRNA) in MIRI;Korean Circulation Journal;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3